These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1968237)

  • 21. Specific D1 and D2 dopamine agonists have synergistic effects in the 6-hydroxydopamine circling model in the rat.
    Rouillard C; Bédard PJ
    Neuropharmacology; 1988 Dec; 27(12):1257-64. PubMed ID: 2907616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glutamate antagonists modify the motor stimulant actions of D1 and D2 agonists in reserpine-treated mice in complex ways that are not predictive of their interactions with the mixed D1/D2 agonist apomorphine.
    Starr MS; Starr BS
    J Neural Transm Park Dis Dement Sect; 1993; 6(3):215-26. PubMed ID: 7907216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reserpine-induced hypothermia and its reversal by dopamine agonists.
    Danielson TJ; Coutts RT; Coutts KA; Keashly R; Tang A
    Life Sci; 1985 Jul; 37(1):31-8. PubMed ID: 4010467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positive interaction between alpha-1 adrenergic and dopamine-2 receptors in locomotor activity of normo and supersensitive mice.
    Rubinstein M; Schinder AF; Gershanik O; Stefano FJ
    Life Sci; 1989; 44(5):337-46. PubMed ID: 2536881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of D1 and D2 dopamine receptors inhibits protein kinase C activity in striatal synaptoneurosomes.
    Giambalvo CT; Wagner RL
    J Neurochem; 1994 Jul; 63(1):169-76. PubMed ID: 7911508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A different balance in the sensitivity of D1 and D2 dopamine receptors accounts for differences in apomorphine-induced hypothermic effects in Swiss and C3H mice.
    Suaudeau C; Bousselmame R; Costentin J
    Neuropharmacology; 1992 Nov; 31(11):1115-9. PubMed ID: 1475020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Importance of D-2 mechanisms in the reversal of reserpine hypothermia in the mouse.
    Volterra G; Borsini F; Meli A
    J Pharm Pharmacol; 1988 Sep; 40(9):638-41. PubMed ID: 2907031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of selective dopamine receptor agonists and antagonists on body temperature in rats.
    Faunt JE; Crocker AD
    Eur J Pharmacol; 1987 Jan; 133(3):243-7. PubMed ID: 2951265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CY 208-243 behaves as a typical D-1 agonist in the reserpine-treated mouse.
    Abbott B; Starr BS; Starr MS
    Pharmacol Biochem Behav; 1991 Feb; 38(2):259-63. PubMed ID: 1676166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Yawning is elicited by D2 dopamine agonists but is blocked by the D1 antagonist, SCH 23390.
    Serra G; Collu M; Gessa GL
    Psychopharmacology (Berl); 1987; 91(3):330-3. PubMed ID: 2882540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SCH 23390 antagonizes apomorphine- and ergot-induced hypothermia.
    Carboni E; Longoni R; Deidda S; Di Chiara G
    Eur J Pharmacol; 1986 Jun; 125(1):17-22. PubMed ID: 3525197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Motor activation in short- and long-term reserpinized mice: role of N-methyl-D-aspartate, dopamine D1 and dopamine D2 receptors.
    Ferré S; Giménez-Llort L; Artigas F; Martínez E
    Eur J Pharmacol; 1994 Apr; 255(1-3):203-13. PubMed ID: 7913043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. D2 dopamine receptor-mediated mechanisms in the medial preoptic-anterior hypothalamus regulate effective defense behavior in the cat.
    Sweidan S; Edinger H; Siegel A
    Brain Res; 1991 May; 549(1):127-37. PubMed ID: 1680019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of the D1 receptor agonist SKF 38393 on some behavioural effects of apomorphine in rats.
    Zarkovsky AM; Cereska KS
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Apr; 339(4):383-6. PubMed ID: 2567965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of D-1 receptor system on the D-2 receptor-mediated hypothermic response in mice.
    Menon MK; Gordon LI; Kodama CK; Fitten J
    Life Sci; 1988; 43(10):871-81. PubMed ID: 2901020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stimulation of D1 dopamine receptors reveals direct effects of the preferential dopamine autoreceptor agonist B-HT 920 on postsynaptic dopamine receptors.
    Andén NE; Grabowska-Andén M
    Acta Physiol Scand; 1988 Oct; 134(2):285-90. PubMed ID: 2852446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repeated reserpine treatment alters firing pattern and responses of substantia nigral dopamine neurons.
    Sun BC; Huang KX; Jin GZ
    Eur J Pharmacol; 1993 Feb; 231(3):331-8. PubMed ID: 8095463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. D1 and D2 dopamine binding site up-regulation and apomorphine-induced stereotypy.
    Chipkin RE; McQuade RD; Iorio LC
    Pharmacol Biochem Behav; 1987 Dec; 28(4):477-82. PubMed ID: 2893388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.